Half- Dose Recombinant Tissue Plasminogen Activator Treatment in Venous Thromboembolism

HASANOĞLU, HATİCE; Hezer, Habibe; Karalezli, Aysegul; Arguder, EMİNE; Kilic, HATİCE; Senturk, Aysegul; Er, Mukremin; Noyturk, Ayse

Half- Dose Recombinant Tissue Plasminogen Activator Treatment in Venous Thromboembolism

HASANOĞLU H. C. , Hezer H., Karalezli A., Arguder E. , Kilic H. , Senturk A., ...More

JOURNAL OF INVESTIGATIVE MEDICINE, vol.62, no.1, pp.71-77, 2014 (Journal Indexed in SCI)

Publication Type: Article / Article
Volume: 62 Issue: 1
Publication Date: 2014
Title of Journal : JOURNAL OF INVESTIGATIVE MEDICINE
Page Numbers: pp.71-77

Abstract

Background Adrenomedullin (AM) is a vasodilator peptide produced by endothelial and smooth muscle cells in the systemic and pulmonary circulation. It promotes angiogenesis and alveolar growth and has protective effects in the cardiovascular and respiratory systems. Adrenomedullin's role in human pulmonary vascular and alveolar development is unknown.